FDA Inspection 1301772 — Dr. Rennan Quijano
The FDA completed an inspection of Dr. Rennan Quijano on January 29, 2026 in Anaheim, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 29, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Anaheim, CA (United States)
Additional Details
Clinical Investigator (CI)